He has held roles of increasing complexity and responsibility in the pharmaceutical industry for more than 20 years, across multiple business units and functional areas in europe, the united states and japan. Cvac) is a global biopharmaceutical company in the field of messenger rna (mrna) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes. Curevac has had approximately 375 employees since may 2018
SURPRISE BBC RADIO LONDON INTERVIEW!! - YouTube
Alexander zehnder, m.d, mba, is chief executive officer at curevac n.v
Since april 01, 2023 and is its managing director since march 2023 and serves as its member of management board since 2023.
Alexander zehnder, md, mba, currently serves as the chief executive officer of curevac since april 2023. Cvac) is a global biopharmaceutical company in the field of messenger rna (mrna) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing. Curevac's key executives include ingmar hoerr and 4 others.
